News | March 12, 2025
CCRH and Adamas University sign MoU to advance homoeopathy research
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
The PIPE offering consists of 36,190,476 units
The company has withdrawn all litigation against Vikas Lifecare Limited post withdrawal of the Alwar Case by VLL
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
Fourth-quarter 2024 revenues totaled $17.8 billion, an increase of $3.2 billion
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
The biosimilar Ustekinumab has been developed and manufactured by the company
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Subscribe To Our Newsletter & Stay Updated
